Loss of the deubiquitylase BAP1 alters class I histone deacetylase expression and sensitivity of mesothelioma cells to HDAC inhibitors.
about
Unexploited Antineoplastic Effects of Commercially Available Anti-Diabetic DrugsCIViC databaseConsensus report of the 2015 Weinman International Conference on MesotheliomaLatest developments in our understanding of the pathogenesis of mesothelioma and the design of targeted therapiesLoss of nuclear BAP1 expression is associated with poor prognosis in oral mucosal melanomaBAP1, a tumor suppressor gene driving malignant mesothelioma.Genomic profiling of malignant peritoneal mesothelioma reveals recurrent alterations in epigenetic regulatory genes BAP1, SETD2, and DDX3X.Malignant Mesothelioma: Time to Translate?Modulating BAP1 expression affects ROS homeostasis, cell motility and mitochondrial function.Malignant Mesothelioma, BAP1 Immunohistochemistry, and VEGFA: Does BAP1 Have Potential for Early Diagnosis and Assessment of Prognosis?Nuclear BAP1 loss is common in intrahepatic cholangiocarcinoma and a subtype of hepatocellular carcinoma but rare in pancreatic ductal adenocarcinoma
P2860
Q26750845-6E6B5912-DD7F-414E-95A6-FE9B0E0FE025Q27612411-E678FDA6-9D50-4920-B093-72D3858D82A4Q27908468-087B5FFF-842D-4C9D-B280-E1BEC118E2F1Q28395597-6B5C14DD-22DE-4CBA-8A25-4104597CA279Q33710012-571040DB-A729-4D25-8531-AFAB394BCF66Q33890512-B6F4E77D-8180-4BF7-B6B3-D3895F913D9BQ37619913-9310A113-FC0C-4DE2-9D32-FF9948C01882Q39366003-C640426B-133E-4610-ACDF-421E0E45E58BQ42700777-7AA4503A-9AB7-4700-A774-CBAAEDB5C8F7Q42728294-C4AAA476-189F-4AD3-BFF2-7AA8C45119D9Q57112789-B0F1BF06-D1CB-47A2-B954-0E6077DBB8FD
P2860
Loss of the deubiquitylase BAP1 alters class I histone deacetylase expression and sensitivity of mesothelioma cells to HDAC inhibitors.
description
2015 nî lūn-bûn
@nan
2015 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
name
Loss of the deubiquitylase BAP ...... ioma cells to HDAC inhibitors.
@ast
Loss of the deubiquitylase BAP ...... ioma cells to HDAC inhibitors.
@en
Loss of the deubiquitylase BAP ...... ioma cells to HDAC inhibitors.
@nl
type
label
Loss of the deubiquitylase BAP ...... ioma cells to HDAC inhibitors.
@ast
Loss of the deubiquitylase BAP ...... ioma cells to HDAC inhibitors.
@en
Loss of the deubiquitylase BAP ...... ioma cells to HDAC inhibitors.
@nl
altLabel
Loss of the deubiquitylase BAP ...... lioma cells to HDAC inhibitors
@en
prefLabel
Loss of the deubiquitylase BAP ...... ioma cells to HDAC inhibitors.
@ast
Loss of the deubiquitylase BAP ...... ioma cells to HDAC inhibitors.
@en
Loss of the deubiquitylase BAP ...... ioma cells to HDAC inhibitors.
@nl
P2093
P2860
P50
P3181
P356
P1433
P1476
Loss of the deubiquitylase BAP ...... ioma cells to HDAC inhibitors.
@en
P2093
Jenna Kenyani
Joseph J Sacco
Michael Denny
Michael J Clague
Rachel Carter
Sarah Darling
Zohra Butt
P2860
P304
13757-13771
P3181
P356
10.18632/ONCOTARGET.3765
P407
P577
2015-05-30T00:00:00Z